Walgreens Boots Alliance, Inc. logo
Walgreens Boots Alliance, Inc. (WBA)
Compare

Walgreens Boots Alliance, Inc. (WBA) Earnings Per Share (EPS): -7.29

Is Walgreens Boots Alliance, Inc.’s earnings per share (EPS) high or low?

Walgreens Boots Alliance, Inc.'s earnings per share (EPS) of -7.29 is 2651% below its 5-year average of -0.26, near the low end of its 5-year range (-10.01–5.02).

As of Saturday, June 13, 2026. 7.36% below its 12-month average of -6.79.

WBA Earnings Per Share (EPS) Chart

WBA Earnings Per Share (EPS)
-10.01-180.39% 1Y
Zoom

WBA Average Earnings Per Share (EPS) Chart

WBA Current vs Average Earnings Per Share (EPS) Chart

WBA Earnings Per Share (EPS) Metrics

EARNINGS PER SHARE (EPS)

-7.29

EARNINGS PER SHARE (EPS) AVG TTM

-6.79

EARNINGS PER SHARE (EPS) AVG 3Y

-1.56

EARNINGS PER SHARE (EPS) AVG 5Y

-0.26

EARNINGS PER SHARE (EPS) AVG 10Y

1.56

EARNINGS PER SHARE (EPS) AVG 15Y

1.84

EARNINGS PER SHARE (EPS) AVG 20Y

1.82

CURRENT VS TTM AVG

-7.36%

CURRENT VS 3Y AVG

-366.56%

CURRENT VS 5Y AVG

-2650.94%

CURRENT VS 10Y AVG

-565.95%

CURRENT VS 15Y AVG

-495.93%

CURRENT VS 20Y AVG

-500.13%

WBA Competitors' Earnings Per Share (EPS)

NAMEMARKET CAPEARNINGS PER SHARE (EPS)TTM3Y5Y
Walgreens Boots Alliance, Inc. (WBA)$10.37B-7.29-6.79-1.56-0.26
Baxter International Inc. (BAX)$10.77B-2.10-1.51-0.650.36
Charles River Laboratories International, Inc. (CRL)$9.03B-3.76-1.354.035.21
Tempus AI, Inc. (TEM)$8.35B-1.72-3.00-2.43-2.16
Align Technology, Inc. (ALGN)$12.52B5.965.645.439.01
Bio-Rad Laboratories, Inc. (BIO)$7.73B6.07-18.74-45.2814.90
The Cooper Companies, Inc. (COO)$13.24B1.181.921.8211.98
Solventum Corporation (SOLV)$13.66B8.175.856.827.06
Hims & Hers Health, Inc. (HIMS)$5.98B-0.090.570.18-0.06
Hologic, Inc. (HOLX)$16.97B2.402.923.224.07

EPS Comparison

Trailing EPS (TTM)

$-7.29

Forward EPS (Est.)

$1.57

P/E Ratio

N/A

Formula: EPS = Net Income / Weighted Average Shares Outstanding

Why EPS matters:

  • Directly impacts stock valuation through P/E ratio
  • Used to calculate dividend coverage and payout ratios
  • Enables comparison across companies of different sizes
  • Growth in EPS often correlates with stock price appreciation

Walgreens Boots Alliance, Inc. Earnings Per Share (EPS) Formula & Definition

EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Walgreens Boots Alliance, Inc. Earnings Per Share (EPS) FAQ

What is the earnings per share (EPS) for Walgreens Boots Alliance, Inc. (WBA)?
The earnings per share (EPS) for WBA stock is -7.29.
Is Walgreens Boots Alliance, Inc.'s earnings per share (EPS) high or low?
Walgreens Boots Alliance, Inc.'s earnings per share (EPS) of -7.29 is 2651% below its 5-year average of -0.26, near the low end of its 5-year range (-10.01–5.02).
What is the TTM average earnings per share (EPS) for Walgreens Boots Alliance, Inc. (WBA)?
The TTM average earnings per share (EPS) for WBA stock is -6.79.
What is the 3Y average earnings per share (EPS) for Walgreens Boots Alliance, Inc. (WBA)?
The 3Y average earnings per share (EPS) for WBA stock is -1.56.
What is the 5Y average earnings per share (EPS) for Walgreens Boots Alliance, Inc. (WBA)?
The 5Y average earnings per share (EPS) for WBA stock is -0.26.
What is the 10Y average earnings per share (EPS) for Walgreens Boots Alliance, Inc. (WBA)?
The 10Y average earnings per share (EPS) for WBA stock is 1.56.
What is the 15Y average earnings per share (EPS) for Walgreens Boots Alliance, Inc. (WBA)?
The 15Y average earnings per share (EPS) for WBA stock is 1.84.
What is the 20Y average earnings per share (EPS) for Walgreens Boots Alliance, Inc. (WBA)?
The 20Y average earnings per share (EPS) for WBA stock is 1.82.

Walgreens Boots Alliance, Inc. Earnings Per Share (EPS) History

DATEEARNINGS PER SHARE (EPS)
2024-08-31-10.01
2023-08-31-3.57
2022-08-315.02
2021-08-312.31
2020-08-310.52
2019-08-314.14
2018-08-315.07
2017-08-313.80
2016-08-313.85
2015-08-314.05
2014-08-312.03
2013-08-312.69
2012-08-312.43
2011-08-312.97
2010-08-312.13
2009-08-312.03
2008-08-312.18
2007-08-312.04
2006-08-311.73
2005-08-311.53
2004-08-311.32
2003-08-311.14
2002-08-311.00
2001-08-310.87
2000-08-310.77
1999-08-310.62
1998-08-310.51
1997-08-310.44
1996-08-310.38
1995-08-310.33

About Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.

Deerfield, IL
193,000 employees
Healthcare / Medical - Pharmaceuticals
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Timothy C. Wentworth